Home Endocrine Diseases

Endocrine Diseases

Positive Results From the Phase III LINC-3 Study of Isturisa® (osilodrostat) for the Treatment of Cushing’s Disease Published in Lancet Diabetes & Endocrinology

Data from the Phase III LINC-3 study, published in Lancet Diabetes & Endocrinology, demonstrate that Isturisa® (osilodrostat) rapidly decreases mean urinary free cortisol...

Is It Time for Lake Hopatcong to Reconsider Triploid Grass Carp?

The summer is half over and boats are starting to go back in the water after such a long hiatus due to the...

Pharma firms found guilty in supply of life-saving drug to NHS

Three pharmaceutical companies conducted illegal activity into the supply of a life-saving medicine, an...

Algae growth a nuisance, but controllable

Katie Parker University of Illinois Extension

Positive Results From the Phase III LINC-3 Study of Isturisa® (osilodrostat) for the Treatment of Cushing’s Disease Published in Lancet Diabetes & Endocrinology

Data from the Phase III LINC-3 study, published in Lancet Diabetes & Endocrinology, demonstrate that Isturisa® (osilodrostat) rapidly decreases mean urinary free cortisol...

Is It Time for Lake Hopatcong to Reconsider Triploid Grass Carp?

The summer is half over and boats are starting to go back in the water after such a long hiatus due to the...

Pharma firms found guilty in supply of life-saving drug to NHS

Three pharmaceutical companies conducted illegal activity into the supply of a life-saving medicine, an...

Algae growth a nuisance, but controllable

Katie Parker University of Illinois Extension

Most Commented

Novavax’s Covid-19 vaccine shows promising immune response

A potential Covid-19 vaccine from the biotech company Novavax showed a promising immune response in a small, early trial, but not without a...

Policy Brief: Education during COVID-19 and beyond (August 2020) – World

Executive summary The COVID-19 pandemic has created the largest disruption of education systems in history, affecting nearly 1.6...

Experts Highlight COVID-19 Vaccine Developments and Remaining Challenges

There are currently more than 160 different vaccine candidates in the pipeline to protect against SARS-CoV-2, the virus that causes coronavirus disease 2019...

Positive Results From the Phase III LINC-3 Study of Isturisa® (osilodrostat) for the Treatment of Cushing’s Disease Published in Lancet Diabetes & Endocrinology

Data from the Phase III LINC-3 study, published in Lancet Diabetes & Endocrinology, demonstrate that Isturisa® (osilodrostat) rapidly decreases mean urinary free cortisol...

Is It Time for Lake Hopatcong to Reconsider Triploid Grass Carp?

The summer is half over and boats are starting to go back in the water after such a long hiatus due to the...

Pharma firms found guilty in supply of life-saving drug to NHS

Three pharmaceutical companies conducted illegal activity into the supply of a life-saving medicine, an...

Algae growth a nuisance, but controllable

Katie Parker University of Illinois Extension

Editor Picks

Novavax’s Covid-19 vaccine shows promising immune response

A potential Covid-19 vaccine from the biotech company Novavax showed a promising immune response in a small, early trial, but not without a...

Policy Brief: Education during COVID-19 and beyond (August 2020) – World

Executive summary The COVID-19 pandemic has created the largest disruption of education systems in history, affecting nearly 1.6...